EU Patient CEntric ClinicAl TRial PLatforms
Budget: €29M (IMI funding programme)
Duration: 2019-2023
Participants: 36 partners
Coordinator: Vall d’Hebron Research Institute (VHIR)

TEAMIT participates in EU-PEARL, a project that is shaping the future of clinical trials, by promoting a new paradigm of collaborative platform trials, where patients play a bigger part in trial designs and outcomes. This innovative approach has the potential to increase patients’ opportunities to gain speedier access to more effective and personalized techniques and treatments.

EU-PEARL is developing this new framework of platform trials to bring more efficiency and speed to the drug development process.